CliffBio
small molecule

OMEPRAZOLE AND SODIUM BICARBONATE

OMEPRAZOLE; SODIUM BICARBONATE

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameOMEPRAZOLE AND SODIUM BICARBONATE
Active ingredientOMEPRAZOLE; SODIUM BICARBONATE
Strength20MG/PACKET;1.68GM/PACKET
Dosage formFOR SUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2025
Marketing statusRX

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.